Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
Objectives: In many current guidelines, blood pressure (BP)-lowering drug treatment for primary prevention of cardiovascular disease (CVD) is based on absolute risk. However, in clinical practice, therapeutic decisions are often based on BP levels alone. We sought to investigate which approach was s...
| Main Authors: | Ho, C., Breslin, M., Doust, J., Reid, Christopher, Nelson, M. |
|---|---|
| Format: | Journal Article |
| Published: |
BM J Group
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/67456 |
Similar Items
POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017)
by: Ho, C., et al.
Published: (2017)
Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017)
by: Ho, C., et al.
Published: (2017)
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018)
by: Ho, C., et al.
Published: (2018)
TEN-YEAR LEGACY EFFECTS OF BASELINE BLOOD PRESSURE TREATMENT NAIVETY IN THE SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY.
by: Nelson, M., et al.
Published: (2015)
by: Nelson, M., et al.
Published: (2015)
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study
by: Nelson, M., et al.
Published: (2015)
by: Nelson, M., et al.
Published: (2015)
Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020)
by: Ho, C.L.B., et al.
Published: (2020)
SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)
by: Ho, C., et al.
Published: (2016)
The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)
by: Ho, Chau L.B., et al.
Published: (2021)
Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
by: Dhaliwal, Satvinder, et al.
Published: (2017)
by: Dhaliwal, Satvinder, et al.
Published: (2017)
FACTORS ASSOCIATED WITH "IN-STUDY" BLOOD PRESSURE CONTROL: FINDINGS FROM THE 2(ND) AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY
by: Chowdhury, E., et al.
Published: (2011)
by: Chowdhury, E., et al.
Published: (2011)
Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Ho, Chau Le Bao, et al.
Published: (2022)
by: Ho, Chau Le Bao, et al.
Published: (2022)
Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study
by: Nelson, M., et al.
Published: (2010)
by: Nelson, M., et al.
Published: (2010)
Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016
by: Si, Si, et al.
Published: (2018)
by: Si, Si, et al.
Published: (2018)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials
by: Czernichow, S., et al.
Published: (2011)
by: Czernichow, S., et al.
Published: (2011)
Blood pressure lowering mechanisms of Kadukmy™ in essential hypertension
by: Mohd Zainudin, Maizura, et al.
Published: (2019)
by: Mohd Zainudin, Maizura, et al.
Published: (2019)
Novel blood pressure-lowering effect of spathulenol in rats
by: Raslan Ain-Fatin,, et al.
Published: (2024)
by: Raslan Ain-Fatin,, et al.
Published: (2024)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)
by: Yusuf, S., et al.
Published: (2016)
Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the Second Australian National Blood Pressure study cohort
by: Nelson, M., et al.
Published: (2009)
by: Nelson, M., et al.
Published: (2009)
A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings
by: Head, G., et al.
Published: (2010)
by: Head, G., et al.
Published: (2010)
NIGHT-TIME AMBULATORY BLOOD PRESSURE IS THE BEST PRETREATMENT BLOOD PRESSURE PREDICTOR OF 11-YEAR MORTALITY IN OLDER HYPERTENSIVES
by: Wing, L., et al.
Published: (2017)
by: Wing, L., et al.
Published: (2017)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
by: Lonn, E., et al.
Published: (2016)
by: Lonn, E., et al.
Published: (2016)
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)
by: Yusuf, Salim, et al.
Published: (2016)
Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives
by: Wing, L., et al.
Published: (2018)
by: Wing, L., et al.
Published: (2018)
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
by: Lonn, Eva M., et al.
Published: (2016)
by: Lonn, Eva M., et al.
Published: (2016)
Prescription of physical activity in the management of high blood pressure in Australian general practices
by: Smith, B., et al.
Published: (2019)
by: Smith, B., et al.
Published: (2019)
Incidence of heart failure in 6083 elderly hypertensive patients: The Second Australian National Blood Pressure Study (ANBP2)
by: Sahle, B., et al.
Published: (2015)
by: Sahle, B., et al.
Published: (2015)
Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals
by: Chowdhury, E., et al.
Published: (2013)
by: Chowdhury, E., et al.
Published: (2013)
Short-and long-term survival in treated elderly hypertensive patients with or without diabetes: Findings from the second Australian national blood pressure study
by: Chowdhury, E., et al.
Published: (2014)
by: Chowdhury, E., et al.
Published: (2014)
Nitrate-rich vegetables do not lower blood pressure in individuals with mildly elevated blood pressure: A 4-wk randomized controlled crossover trial
by: Blekkenhorst, L., et al.
Published: (2018)
by: Blekkenhorst, L., et al.
Published: (2018)
Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)
by: Owen, A., et al.
Published: (2009)
Alcohol, Blood Pressure and Hypertension
by: Puddey, I., et al.
Published: (2005)
by: Puddey, I., et al.
Published: (2005)
Lipid and blood pressure lowering effects of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2023)
by: Shafie, Nurul Husna, et al.
Published: (2023)
Lipid and blood pressure lowering potential of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2020)
by: Shafie, Nurul Husna, et al.
Published: (2020)
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
by: Chowdhury, E., et al.
Published: (2014)
by: Chowdhury, E., et al.
Published: (2014)
Control of blood pressure after stroke
by: Bath, Philip M.W., et al.
Published: (2006)
by: Bath, Philip M.W., et al.
Published: (2006)
Blood pressure management in acute stroke
by: Appleton, Jason P., et al.
Published: (2016)
by: Appleton, Jason P., et al.
Published: (2016)
Response to "analysis and interpretation of 24-h blood pressure profiles" [1]
by: Head, G., et al.
Published: (2008)
by: Head, G., et al.
Published: (2008)
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Bennett, A., et al.
Published: (2017)
by: Bennett, A., et al.
Published: (2017)
Potential Benefits of Exercise on Blood Pressure and Vascular Function
by: Pal, Sebely, et al.
Published: (2013)
by: Pal, Sebely, et al.
Published: (2013)
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes
by: Campbell, D., et al.
Published: (2013)
by: Campbell, D., et al.
Published: (2013)
Similar Items
-
POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017) -
Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017) -
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018) -
TEN-YEAR LEGACY EFFECTS OF BASELINE BLOOD PRESSURE TREATMENT NAIVETY IN THE SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY.
by: Nelson, M., et al.
Published: (2015) -
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study
by: Nelson, M., et al.
Published: (2015)